How Vietnam Medical Device Registration Works (Timelines, Fees, & AR Strategy)

Entering one of Southeast Asia's fastest-growing healthcare markets begins with a simple question: How does Vietnam medical device registration work? As demand for imported medical devices increases, the country offers significant opportunities for foreign manufacturers, but only those that successfully navigate Vietnam's regulatory requirements can legally place their products on the market.

While the registration framework is well established, market access involves more than simply submitting an application. Before the registration process even begins, manufacturers must:

• Determine the correct registration pathway
• Understand how device classification affects review requirements
• Appoint a local authorized representative (AR)
• Plan for approval timelines, government fees, and long-term license ownership

Keep reading for an overview of Vietnam’s medical device registration timelines, fees, and classification system, as well as the strategic advantages of partnering with an independent license holder like Cisema. Or, for support with medical device registration in Vietnam, contact Cisema today.

Understanding Vietnam's Medical Device Registration Framework

Before considering timelines or preparing documentation, it is important to understand how Vietnam regulates medical devices. The country's regulatory framework is administered by the Ministry of Health (MOH) through the Infrastructure and Medical Device Administration (IMDA) under Decree No. 98/2021/ND-CP, together with subsequent amendments.

The framework establishes requirements for:

• Medical device classification
• Market authorization
• Importer and Authorized Representative responsibilities
• Post-market surveillance
• Ongoing regulatory compliance

Unlike some jurisdictions, foreign manufacturers cannot submit registration applications directly. Every overseas manufacturer must appoint a locally established Authorized Representative that acts on its behalf throughout the registration lifecycle. Understanding this structure provides the foundation for every other regulatory decision.

What Does the Vietnam Medical Device Registration Process Look Like?

Navigating Vietnam’s regulatory landscape requires a structured, step-by-step approach. While the exact requirements depend on your device's classification, the core registration lifecycle generally follows five key phases:

Step 1: Appoint an Authorized Representative

The first critical decision for foreign manufacturers is selecting an Authorized Representative. Because foreign entities cannot submit applications directly, Vietnamese regulations require you to designate a locally established AR to act on your behalf across all registration and post-market activities.

More than an administrative point of contact, your AR acts as the legal registration holder, interfaces directly with the MOH, and manages regulatory compliance throughout the product's lifecycle.

Core AR responsibilities typically include:

• Submitting registration applications or declarations
• Managing all official communication and regulatory inquiries with the MOH
• Maintaining up-to-date registration information and coordinating product changes
• Supporting post-market reporting and field safety corrective actions
• Managing administrative updates, renewals, and ongoing compliance

While appointing a local distributor as your AR might initially seem convenient since they already handle sales and importation, combining regulatory control with commercial distribution creates heavy dependency. If you ever need to replace an underperforming partner, you risk facing difficult negotiations or legal roadblocks over access to your registration records and technical dossiers.

Partnering with an independent Authorized Representative cleanly separates regulatory oversight from sales channels, allowing you to appoint multiple distributors, replace partners, or restructure your route to market without disrupting regulatory continuity.

Step 2: Confirm Device Classification

After appointing an AR, manufacturers must determine the correct classification for each medical device. This classification dictates the type of application, dossier depth, and review level:

Lower-risk devices (Class A and B) generally follow a simplified registration pathway without dossier review from the authorities, while higher-risk devices (Class C and D) require a comprehensive regulatory review before market approval.

A classification error can affect the entire submission, potentially leading to the wrong application pathway, insufficient technical documentation, additional regulator questions, or the need to restart parts of the process.

Step 3: Prepare the Registration Dossier

Once the appropriate pathway has been confirmed, manufacturers can begin preparing the registration application. The scope of documentation depends on the device classification and registration pathway but typically includes both administrative and technical documents.

Essential components include:

• Legal documentation (Business License of the AR, Letter of Authorization/Power of Attorney)
• Valid ISO 13485 certificate for the manufacturing site
• Certificate of Free Sale (CFS) from the country of origin
• Technical files or CSDT documentation (for Class C/D)
• Compliant product labels and a Vietnamese translation of the Instructions for Use (IFU)

Rather than covering every required document here, we recommend reading our dedicated guide to preparing a Vietnam medical device registration dossier, which provides a complete document checklist, formatting requirements, legalization requirements, and common submission mistakes.

Step 4: Submit the Application and Manage Review

The AR submits the applicable declaration or registration application through the relevant Vietnamese system.

For procedures involving regulatory review, the authority may request clarification, corrected documentation, or additional evidence. The manufacturer should prepare internal subject-matter experts to respond promptly, especially when questions concern engineering, clinical evidence, software functions, or risk management.

Timely responses help maintain momentum, but speed should not come at the expense of accuracy. An incomplete answer may generate another review cycle and extend the overall project. The AR should coordinate responses, confirm that Vietnamese and English documentation remain consistent, and maintain a clear record of all communications.

Step 5: Secure Registration Approval

Once the application satisfies the Ministry of Health's requirements, the device is approved, listed in the IMDA database, and may be legally placed on the Vietnamese market, subject to ongoing post-market obligations.

Note on Validity: Under Decree 98, standard medical device registration numbers are valid indefinitely (they do not expire after 5 years, unlike previous rules).

Registration alone does not complete market access. Before commercialization, the responsible companies must also address applicable requirements concerning labeling, importation, distribution, pricing disclosure where relevant, advertising, traceability, and post-market responsibilities.

Vietnam Medical Device Registration Timelines & Fees

Actual medcial device approval timelines in Vietnam timelines depend on several factors, including:

• Device classification
• Completeness of the submission
• Regulatory pathway
• Responsiveness during review

Government fees are assessed per application, making product grouping an important consideration for manufacturers with broader portfolios. Where permitted under Vietnamese regulations, grouping related products into families or systems can reduce both application volume and overall registration costs.

Note: These are standard registration fees, but a temporary 50% government reduction applies until December 31, 2026.

Can Foreign Approvals Support Faster Medical Device Registration?

Vietnam recognizes approvals issued by several established regulatory authorities worldwide. Depending on the circumstances, devices already approved by recognized reference agencies may qualify for a streamlined review pathway.

Recognized authorities include:

• Therapeutic Goods Administration (TGA) - Australia
• Health Canada - Canada
• European Union member countries
• Ministry of Health, Labour and Welfare (MHLW) / Pharmaceuticals and Medical Devices Agency (PMDA) – Japan
• U.S. Food and Drug Administration (FDA) - United States
• Medicines and Healthcare products Regulatory Agency (MHRA) - United Kingdom
• Swissmedic – Switzerland
• Ministry of Food & Drug Safety (MFDS) – Korea
• National Medical Products Administration (NMPA) - China

Manufacturers with existing approvals from these regulators may benefit from shorter review times compared to standard registration pathways. For a detailed explanation of eligibility requirements and supporting documentation, see our guide to Vietnam's Fast Track medical device registration pathway.

Strategic Advantage: Partnering with an Independent License Holder

Registration is only the beginning of a product's lifecycle in Vietnam. Who holds the registration can affect future commercial decisions, including changing distributors, expanding sales channels, or restructuring regional operations.

Partnering with an independent license holder, such as Cisema, rather than a distributor-linked Authorized Representative offers clear strategic benefits:

• Ownership of your registrations and technical documentation
• Flexibility to appoint or change distributors without re-registration
• Continuity of market access regardless of commercial changes
• Stronger control over compliance and long-term market strategy

This approach gives foreign manufacturers long-term flexibility, stronger control over compliance, and a more resilient market presence.

Final Thoughts

Vietnam's medical device regulatory framework provides a clear pathway for foreign manufacturers, but successful market entry depends on more than simply submitting an application. Choosing the appropriate registration strategy, appointing the right Authorized Representative, understanding classification requirements, and planning for timelines and costs all contribute to a more efficient approval process.

Once these strategic decisions are made, the next step is preparing a compliant submission. Our companion guide to Vietnam medical device dossier requirements explains the documents, formatting requirements, legalization procedures, and common mistakes that manufacturers should understand before applying.

If you need support with Vietnam medical device registration, get in touch with Cisema today. With a local office in Vietnam, Cisema can assist with Authorized Representative services, regulatory strategy, dossier review, submission management, and ongoing compliance throughout your product's lifecycle.

Further Information

• Discover more about Cisema's medical device registration service in Vietnam.
• Read our complete guide to preparing a dossier for medical device registration in Vietnam for a detailed step-by-step overview of regulatory requirements.
• Learn about Vietnam’s Fast Track pathway for medical device registration to shorten approval timelines and accelerate access to the market.

About the Author: Rosie Nguyen

Rosie Nguyen is a Regulatory Affairs Manager at Cisema with over 8 years of experience in cosmetics and medical device regulations in Vietnam. Based in Ho Chi Minh City, she has supported numerous brands in successfully entering the Vietnamese market by ensuring full compliance with product registration and regulatory compliance.

References

• Vietnam Ministry of Health (MOH) – Official government portal for healthcare policies, medical device regulations, and registration updates.
• Infrastructure and Medical Device Administration (IMDA) – Official online portal for medical device registration submissions and public registration listings.
• Decree No. 98/2021/ND-CP – On the management of medical devices (effective 8 Nov 2021)
• Decree No. 07/2023/NĐ-CP – Amending and supplementing certain articles of Decree 98/2021 (effective 3 Mar 2023)
• Decree No. 04/2025/ND-CP – Latest amendments to Decree 98/2021 and Decree 07/2023 (effective 1 Jan 2025)
• Refer to Appendix I, Circular 05/2022/TT-BYT – For official application form templates and dossier formatting guidance.
• Notice No. 645/TB-HTTB: Regarding the change in fee collection rates in the medical device sector